Asked by: Chris Coghlan (Liberal Democrat - Dorking and Horley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure Trusts uphold their legal obligations under the (a) Equality Act 2010 and (b) duty of care for staff returning from serious illness such as cancer.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
We hugely value all National Health Service staff and are committed to improving organisational culture and working conditions, so we can keep staff healthy, motivated, and retain their valuable skills.
A cancer diagnosis is regarded as a disability under the Equality Act 2010, which means that employers have a duty of care to consider any reasonable adjustments to help the employee to return to work in a timely and safe way, and with their health needs in mind.
NHS trusts are expected to have local policies and procedures in place to support staff who have long-term health conditions, including cancer.
The NHS Terms and Conditions of Service handbook sets out interventions that should be considered under the Employment Rights Act 1996 when managing an employee’s return to work. There are tools and resources available to employers to assist their employees returning to work, and this includes NHS England’s NHS Health and Wellbeing framework, and the Sickness Absence toolkit published by NHS Employers. Further information on the NHS Health and Wellbeing framework and the Sickness Absence toolkit is available, respectively, at the following two links:
https://www.nhsemployers.org/toolkits/sickness-absence-toolkit
Asked by: Chris Coghlan (Liberal Democrat - Dorking and Horley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the effectiveness of not including prostate cancer referral guidance for asymptomatic men in National Institute for Health and Care Excellence guidelines.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Institute for Health and Care Excellence’s (NICE) guidelines on prostate cancer relate to symptomatic patients. Guidance on prostate cancer referral for asymptomatic men can be found in the Prostate Cancer Risk Management Programme, which is available at the following link:
https://www.gov.uk/guidance/prostate-cancer-risk-management-programme-overview
NICE guidelines do not provide guidance on screening of asymptomatic people which is the responsibility of the UK National Screening Committee.
Asked by: Chris Coghlan (Liberal Democrat - Dorking and Horley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to his letter to the hon. Member for Dorking and Horley, dated 4 June 2025, if he will set out the legislative vehicles his Department are considering to address the identified shortcomings in mental capacity law.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
On 4 June 2025, I wrote to Fiona Laskaris and the Hon. Member for Dorking and Horley, Chris Coghlan MP to confirm my commitment to review the full range of policy and legislative levers in relation to the practical application of mental capacity law. This important work requires careful consideration. The most recent meeting with officials was on 17 June, and we will set out our plans in due course.
Asked by: Chris Coghlan (Liberal Democrat - Dorking and Horley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what his Department's planned timetable is for its public consultation on the application of mental capacity law.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
On 4 June 2025, I wrote to Fiona Laskaris and the Hon. Member for Dorking and Horley, Chris Coghlan MP to confirm my commitment to review the full range of policy and legislative levers in relation to the practical application of mental capacity law. This important work requires careful consideration. The most recent meeting with officials was on 17 June, and we will set out our plans in due course.
Asked by: Chris Coghlan (Liberal Democrat - Dorking and Horley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what oversight exists to (a) monitor and (b) audit legal expenditure by NHS Trusts in Employment Tribunal cases.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
Neither the Department nor NHS England monitor or audit legal expenditure by National Health Service trusts in Employment tribunal cases. NHS trusts are responsible for overseeing their own Employment Tribunal cases, which would include monitoring and auditing the legal expenditure. Legal expenditure in Employment Tribunal cases may however be subject to financial audit scrutiny by the NHS trusts’ external auditors, subject to local audit materiality.
Asked by: Chris Coghlan (Liberal Democrat - Dorking and Horley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what his planned timetable is for completion of the TRANSFORM trial into prostate cancer screening.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The TRANSFORM study, funded in partnership with Prostate Cancer UK, will look at new ways of screening for prostate cancer, and will include a national randomised control trial that will provide the definitive data for policymakers to decide on whether screening for prostate cancer should be recommended. The study is broken down into three phases: Phase 1, between 2025 and 2027; Phase 2, between 2028 and 2033; and Phase 3, between 2034 and 2043.
Phase 1 is focusing on making the trial run smoothly, testing a number of different possible screening approaches, and also determining the best way to engage men in the community to take part in the study. Critically, it is also determining the best form of randomisation to carry out. Recruitment for phase one is currently open.
Phase 2 will take forward the most robust randomisation strategy and the most promising screening approach or approaches with tens of thousands of consenting participants, in order to prove that these new screening strategies are beneficial.
Phase 3 will involve monitoring the trial participants over the following 10 years to determine the long-term impact of screening on rates of disease progression and survival.
Asked by: Chris Coghlan (Liberal Democrat - Dorking and Horley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of (a) collating and (b) publishing NHS tribunal data.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
This information is not held centrally by the Department or NHS England. There are currently no plans for an analysis of the potential merits of collating and publishing National Health Service tribunal data.
Asked by: Chris Coghlan (Liberal Democrat - Dorking and Horley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of producing a national strategy to help improve (a) access to and (b) the quality of eating disorder services.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
NHS England is currently refreshing guidance on children and young people's eating disorders. The refreshed guidance will highlight the importance of awareness and early recognition of eating disorders within schools, colleges, primary care, and broader children and young peoples’ mental health services.
The Government is currently developing the 10-Year Health Plan, which will consider the views of a wide range of stakeholders, including those with lived experience of eating disorders. The consultation process has provided invaluable feedback, and we are in the process of exploring how we best take this forward.
Asked by: Chris Coghlan (Liberal Democrat - Dorking and Horley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of (a) establishing an NHS information campaign to raise awareness of prostate cancer referral routes for GPs and (b) issuing specific guidance to GPs on informing patients about the (i) NICE and (ii) PCRMP referral routes.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government takes the management of the risk of prostate cancer seriously. Too many men are waiting too long for diagnosis and treatment, and this must change. We have asked the UK National Screening Committee to look at the evidence for screening for prostate cancer and we will await their findings before making an evidence-based decision.
A public awareness campaign at this stage would not be appropriate. The National Institute for Health and Care Excellence’s guidance relates to symptomatic patients, while the Prostate Cancer Risk Management Programme is guidance for general practitioners (GPs) on how to counsel non-symptomatic men about the risks associated with using the current best test for prostate cancer, because of its lack of accuracy. Before we direct asymptomatic individuals to GPs, we need a better test, and that is why the Government has invested £16 million into the TRANSFORM trial, which is looking for more effective ways of accurately detecting prostate cancer.
Asked by: Chris Coghlan (Liberal Democrat - Dorking and Horley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of resolving NHS employment disputes early.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department has not made this specific assessment. National Health Service employment disputes arising at a local level are for employers to manage and resolve locally. At a national level, the Government has prioritised improving industrial relations following the General Election in July 2024. The deal we agreed with resident doctors in England, negotiated within four weeks of being in Government, brought an end to their prolonged strikes and we will continue to work with resident doctors to improve their working lives and keep them in the NHS.
Our ambition remains to reset the relationship between the Government and all NHS staff, and we want to work collaboratively with trade unions to address concerns and foster a productive and positive relationship with the NHS workforce.